$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
New Highs: Novo Nordisk, PGT Innovations Among Best Stocks To Buy Now
01:34pm, Friday, 24'th Nov 2023
Novo Nordisk and PGT Innovations continue to show relative strength and are among the best stocks to buy now.
Novo Nordisk (NVO) to Expand Manufacturing Site in France
11:17am, Friday, 24'th Nov 2023
Novo Nordisk (NVO) announces that it is initiating plans to expand its existing manufacturing facility in Chartres, France, for the current and future product portfolio within serious chronic diseases
Pharma Stock Hits Record High After Expansion Plans
10:41am, Friday, 24'th Nov 2023
Pharmaceutical name Novo Nordisk A/S (NYSE:NVO) is up 1.6% at $104.93 at last glance, earlier hitting a fresh record peak of $105.30.
Eli Lilly and Novo Nordisk will remain winners in the weight-loss category: Barclays' Emily Field
09:52am, Friday, 24'th Nov 2023
Emily Field, Barclays, joins 'Squawk Box' to discuss the latest news in the weight-loss drug market, the news to watch out for next year, and how investors should play the weight-loss drug market.
New Strong Buy Stocks for November 24th
08:16am, Friday, 24'th Nov 2023
NVO, PAY, AIZ, MOD and LEU have been added to the Zacks Rank #1 (Strong Buy) List on November 24, 2023.
7 Stocks Set to Capitalize on the Coming Year-End Rally
07:00am, Friday, 24'th Nov 2023
The story of the stock market in 2023 has largely been about optimism around AI tinged by the continued threat of recession. Generative AI has propelled tech shares much higher.
Novo Nordisk to invest $2 billion in France production boost
03:17am, Friday, 24'th Nov 2023
Weight loss drug developer Novo Nordisk (NYSE:NVO) has announced US$2.3 billion will be spent on ramping up production in France. Set to boost capacity, quality control lab space, aseptic and finished
Ozempic maker plans manufacturing blitz as market for the drug is expected to top $100 billion in 2030
05:08pm, Thursday, 23'rd Nov 2023
Novo Nordisk makes Ozempic and Wegovy, two hit drugs that treat obesity. Supply is a major issue right now, with the firm warning a European regulator it may ration Ozempic.
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
09:26am, Thursday, 23'rd Nov 2023
The hype seems eerily familiar, but Novo Nordisk's weight-loss drug may well meet lofty sales expectations. Despite plenty of headaches, Boeing is showing strength in front of a massive wave of demand
Novo Nordisk to launch obesity drug Wegovy in Japan in February
09:08am, Thursday, 23'rd Nov 2023
Novo Nordisk said on Thursday it will launch its hugely popular Wegovy obesity drug in Japan on Feb. 22 next year.
Novo Nordisk invests $2.3 mln in France to boost output
04:36am, Thursday, 23'rd Nov 2023
Danish drug maker Novo Nordisk said on Thursday it would invest more than 16 billion crowns ($2.34 billion) in the expansion of production facilities in Chartres in France.
Macron to unveil 2.1 bln eur Novo Nordisk pharma investment in France
12:09am, Thursday, 23'rd Nov 2023
French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish pharmaceutical company Novo Nordisk in France, his office said, pitching it as a sig
3 Consumer Goods Stocks That Will Define the Next Decade
11:49am, Tuesday, 21'st Nov 2023
What will the next decade bring and how will we be living in the 2030s? It's a question marketing professionals and traders spend a lot of time trying to figure out as they forecast which stocks will
Medicare's exclusion of weight-loss drug coverage under fire
12:26pm, Monday, 20'th Nov 2023
Medicare's decades-old exclusion of weight-loss drug coverage is coming under scrutiny amid mounting evidence that Wegovy and similar medications have health benefits that extend well beyond shedding
Weight loss drugs Wegovy and Zepbound to debut in pill form
10:51am, Friday, 17'th Nov 2023
Popular weight loss drugs Wegovy and Zepbound will soon be available in pill form. Pharmaceutical giants Novo Nordisk (NYSE:NVO) and Eli Lilly and Co (NYSE:LLY) are actively promoting pill versions of
Sign In
Buy NVO